No Elevated Risk for Osteoporosis or Osteopenia Among Women With Androgenetic or Frontal Fibrosing Alopecia Treated With 5-Alpha Reductase Inhibitors: A Retrospective TriNetX Cohort Study
January 2026
in “
Journal of the American Academy of Dermatology
”
Studysummary 5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jaad.org →